Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase II trial to evaluate Pentrix in prostate cancer

July 4, 2003

Antisoma initiates enrollment in phase I study of R-1550 in breast cancer

July 4, 2003

Preclinical studies support use of MT-103 for chronic lymphocytic leukemia

July 1, 2003

CPMP hands down positive opinion for survival claim for MabCampath

June 30, 2003

Preliminary findings for Ceplene in stage IV malignant melanoma

June 26, 2003

Phase III Theratope vaccine trial fails to meet primary endpoints

June 19, 2003

Interferon alfa variants with enhanced immunomodulatory and antitumor activity

June 17, 2003

Dendreon's phase III trial will serve as basis for Provenge approval

June 17, 2003

Preliminary evidence of immune response reported in Norelin trial

June 16, 2003

3M submits sNDA for Aldara in superficial basal cell carcinoma

June 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...